Your browser doesn't support javascript.
COVID-19 Vaccination Rates in a Global HIV Cohort.
Fulda, Evelynne S; Fitch, Kathleen V; Overton, Edgar T; Zanni, Markella V; Aberg, Judith A; Currier, Judith S; Lu, Michael T; Malvestutto, Carlos; Fichtenbaum, Carl J; Martinez, Esteban; Umbleja, Triin; Douglas, Pamela S; Ribaudo, Heather J; Grinspoon, Steven K.
  • Fulda ES; Metabolism Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Fitch KV; Metabolism Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Overton ET; Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Zanni MV; Metabolism Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Aberg JA; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Currier JS; Division of Infectious Diseases, University of California at Los Angeles, Los Angeles, California, USA.
  • Lu MT; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Malvestutto C; Division of Infectious Diseases, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Fichtenbaum CJ; Department of Medicine for Translational Research, University of Cincinnati, Cincinnati, Ohio, USA.
  • Martinez E; Hospital Clinic and University of Barcelona, Barcelona, Spain.
  • Umbleja T; Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Douglas PS; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.
  • Ribaudo HJ; Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Grinspoon SK; Metabolism Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
J Infect Dis ; 225(4): 603-607, 2022 02 15.
Article in English | MEDLINE | ID: covidwho-1522224
ABSTRACT
Little is known regarding coronavirus disease 2019 (COVID-19) vaccination rates in people with HIV (PWH), a vulnerable population with significant morbidity from COVID-19. We assessed COVID-19 vaccination rates among 6952 PWH in the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) compared to region- and country-specific vaccination data. The global probability of COVID-19 vaccination through end of July 2021 was 55% among REPRIEVE participants with rates varying substantially by Global Burden of Disease (GBD) superregion. Among PWH, factors associated with COVID-19 vaccination included residence in high-income regions, age, white race, male sex, body mass index, and higher cardiovascular risk. Clinical Trials Registration. NCT02344290.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / Vaccination / COVID-19 Vaccines / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans / Male Language: English Journal: J Infect Dis Year: 2022 Document Type: Article Affiliation country: Infdis

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / Vaccination / COVID-19 Vaccines / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans / Male Language: English Journal: J Infect Dis Year: 2022 Document Type: Article Affiliation country: Infdis